An <i>in silico</i> drug repurposing approach to identify HDAC1 inhibitors against glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An in silico drug repurposing approach to identify HDAC1 inhibitors against glioblastoma

Published:2024-04-30 Issue: Volume: Page:1-14
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Gopinathan Adarsh¹,Sankhe Runali¹,Rathi Ekta²,Kodi Triveni¹,Upadhya Raghavendra³,Pai K. Sreedhara Ranganath¹,Kishore Anoop¹

Affiliation:

1. Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India

2. Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India

3. Manipal Center for Biotherapeutics Research, Manipal Academy of Higher Education, Manipal, Karnataka, India

Funder

Indian Council of Medical Education

ICMR Ad-Hoc

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2024.2335293

Reference51 articles.

1. Glioblastome Multiforme: A Bibliometric Analysis

2. Expression and Immunolocalisation of Neutral Endopeptidase in Prostate Cancer

3. In-silico lead identification of the pan-mutant IDH1 and IDH2 inhibitors to target glioblastoma

4. The Transcriptionally Active Amyloid Precursor Protein (APP) Intracellular Domain Is Preferentially Produced from the 695 Isoform of APP in a β-Secretase-dependent Pathway

5. Recent developments of HDAC inhibitors: Emerging indications and novel molecules

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP